Product Information

NAPROXEN 250 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0528 per EA under NDC 68462018801. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NAPROXEN 250 MG TABLET

Naproxen
$0.0528per EA

Strength

250 mg/1

NDC

68462018801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NAPROXEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078250

FDA Approved

3/28/2007

TE Code

AB

On Market Since

7/1/2007

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for NAPROXEN 250 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 38.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0528 per EA
All-time high$0.0656 (Mar 13, 2024)
All-time low$0.0311 (Jul 17, 2024)
52-week high$0.0528
52-week low$0.0434
Median price$0.0500
Average price$0.0490
Largest weekly change+50.1% (Aug 21, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+6.6%

1M

+6.6%

3M

+20.6%

6M

+12.9%

1Y

+12.2%

3Y

+0.4%

5Y

-11.7%

All

+38.3%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NAPROXEN 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 250 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0528 per EA (NDC 68462018801), effective Nov 18, 2026.

How has the price of NAPROXEN 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for NAPROXEN 250 MG TABLET has risen 38.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NAPROXEN 250 MG TABLET?

Since Nov 28, 2013, the NADAC for NAPROXEN 250 MG TABLET has ranged from a low of $0.0311 (Jul 17, 2024) to a high of $0.0656 (Mar 13, 2024), with a median of $0.0500 per EA.

Are there cheaper alternatives to NAPROXEN 250 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NAPROXEN 250 MG TABLET, is $0.0487 per EA — about 8% below NAPROXEN 250 MG TABLET.

Who manufactures NAPROXEN 250 MG TABLET?

NAPROXEN 250 MG TABLET (NDC 68462018801) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.